Notifications Bell

Stocks traded higher after dovish Fed minutes - Thursday Review, April 8

Stocks traded higher after dovish Fed minutes - Thursday Review, April 8

USA500 and UK100 reached new highs, boosted by hopes of a global economic recovery

The US

Wall Street closed in the green, with investors switching focus from the high number of unemployment claims to Fed’s minutes. USA30 rose 0.17%, while USA500 climbed 0.42%. TECH100 went up 1.03%.

Oil rose 0.12% to hit $59.84 per barrel.

Gold was up 0.93% to $1,757.80 per ounce.

The Dollar Index lost 0.42% and traded at 92.085.

Asia and Australia

As investors focused on the US Federal Reserve’s plan to continue with its supportive monetary policy, markets were mixed.

Japan225 fell 0.42% even though the balance of payments data released was positive.

HongKong45 rose 1.%.

Down under, Australia200 rose 1%.

USD/JPY fell 0.52% to 109.27.


Stocks traded higher, boosted by expectations of a global economic recovery. The surge was driven by the Federal Reserve’s minutes which reiterated its easy monetary policy. Germany30 traded 0.2% higher, while France40 rose 0.5%. UK100 reached a 52-week high after it gained 0.3%.

Brent oil rose 0.27% to $63.33 a barrel.

EUR/USD was up 0.38% at 1.1915.


This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent.

Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of